Literature DB >> 33474672

Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

Fanchon Bourasset1,2, Sylvain Auvity1,2, Robert G Thorne3,4, Jean-Michel Scherrmann5,6.   

Abstract

Neuropharmacokinetics considers cerebral drug distribution as a critical process for central nervous system drug action as well as for drug penetration through the CNS barriers. Brain distribution of small molecules obeys classical rules of drug partition, permeability, binding to fluid proteins or tissue components, and tissue perfusion. The biodistribution of all drugs, including both small molecules and biologics, may also be influenced by specific brain properties related to brain anatomy and physiological barriers, fluid dynamics, and cellular and biochemical composition, each of which can exhibit significant interspecies differences. All of these properties contribute to select optimal dosing paradigms and routes of drug delivery to reach brain targets for classical small molecule drugs as well as for biologics. The importance of these properties for brain delivery and exposure also highlights the need for efficient new analytical technologies to more comprehensively investigate drug distribution in the CNS, a complex multi-compartmentalized organ system.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Brain barriers; Cerebral fluids; Delivery routes; Distribution; Extracellular fluid; Heterogeneity

Mesh:

Substances:

Year:  2022        PMID: 33474672     DOI: 10.1007/164_2020_402

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  64 in total

1.  Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data.

Authors:  M Bauer; M Zeitlinger; R Karch; P Matzneller; J Stanek; W Jäger; M Böhmdorfer; W Wadsak; M Mitterhauser; J P Bankstahl; W Löscher; M Koepp; C Kuntner; M Müller; Oliver Langer
Journal:  Clin Pharmacol Ther       Date:  2011-12-14       Impact factor: 6.875

Review 2.  Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier--towards a mechanistic IVIVE-based approach.

Authors:  Kathryn Ball; François Bouzom; Jean-Michel Scherrmann; Bernard Walther; Xavier Declèves
Journal:  AAPS J       Date:  2013-06-20       Impact factor: 4.009

Review 3.  The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?

Authors:  N Joan Abbott; Michelle E Pizzo; Jane E Preston; Damir Janigro; Robert G Thorne
Journal:  Acta Neuropathol       Date:  2018-02-10       Impact factor: 17.088

4.  Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels.

Authors:  Hajar Al Feteisi; Zubida M Al-Majdoub; Brahim Achour; Narciso Couto; Amin Rostami-Hodjegan; Jill Barber
Journal:  J Neurochem       Date:  2018-08-01       Impact factor: 5.372

5.  Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.

Authors:  Hans-Gert Bernstein; Gloria Hölzl; Henrik Dobrowolny; Jens Hildebrandt; Kurt Trübner; Markus Krohn; Bernhard Bogerts; Jens Pahnke
Journal:  Mech Ageing Dev       Date:  2014-09-10       Impact factor: 5.432

6.  Insight into the cooperation of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) at the blood-brain barrier: a case study examining sorafenib efflux clearance.

Authors:  Sagar Agarwal; William F Elmquist
Journal:  Mol Pharm       Date:  2012-02-22       Impact factor: 4.939

Review 7.  Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.

Authors:  Tamima Ashraf; Amy Kao; Reina Bendayan
Journal:  Adv Pharmacol       Date:  2014-08-22

8.  The Scalable Brain Atlas: Instant Web-Based Access to Public Brain Atlases and Related Content.

Authors:  Rembrandt Bakker; Paul Tiesinga; Rolf Kötter
Journal:  Neuroinformatics       Date:  2015-07

9.  Transporter-mediated L-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells.

Authors:  Shin-ichi Akanuma; Tatsuhiko Sakurai; Masanori Tachikawa; Yoshiyuki Kubo; Ken-ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2015-04-29

10.  Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study.

Authors:  Martin Bauer; Rudolf Karch; Markus Zeitlinger; Cécile Philippe; Kerstin Römermann; Johann Stanek; Alexandra Maier-Salamon; Wolfgang Wadsak; Walter Jäger; Marcus Hacker; Markus Müller; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.